Brevan Howard Capital Management LP

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1512857 ST. HELIER, Y9

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,233,985

+$975,924 QoQ

Shares Held

1,979

+492.5% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#607

of 1,322 holders

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Brevan Howard Capital Management LP holds $183,834,510 across 129 Biotechnology names. REGN ranks #32 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	517,621	$18,318,607
2	MRNA	Moderna, Inc.	181,105	$12,682,782
3	BBIO	BridgeBio Pharma, Inc.	155,727	$11,598,546
4	VRTX	Vertex Pharmaceuticals Inc / Ma	17,622	$8,753,376
5	AXSM	Axsome Therapeutics, Inc.	31,928	$7,815,015
6	DFTX	Definium Therapeutics, Inc.	156,812	$7,376,435
7	SNDX	Syndax Pharmaceuticals Inc	309,065	$6,756,160
8	INCY	Incyte Corp	45,270	$5,131,807

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,233,985	1,979	+492.5%	Shares	Defined	2026-08-14
2026-03-31	$258,061	334	-98.3%	Shares	Defined	2026-05-15
2025-12-31	$15,425,821	19,985	+281.4%	Shares	Defined	2026-02-17
2025-09-30	$2,946,294	5,240	-21.6%	Shares	Defined	2025-11-14
2025-06-30	$3,508,050	6,682	-9.0%	Shares	Defined	2025-08-14
2025-03-31	$4,654,613	7,339	-4.6%	Shares	Defined	2025-05-15
2024-12-31	$5,477,816	7,690	+141.5%	Shares	Defined	2025-02-14
2024-09-30	$3,347,147	3,184	+2.5%	Shares	Defined	2024-11-14
2024-03-31	$2,989,493	3,106	+167.1%	Shares	Defined	2024-05-15
2023-12-31	$1,021,451	1,163	—	Shares	Defined	2024-02-14
No filing history on record for this holder in this stock.